It is worth noting that this research is longstanding, with some of the earliest studies dating back to 1998
macular degeneration is only one
at the agent-level, tirzepatide demonstrated comparable efficacy to individual GLP-1RAs
Some people may experience mild side effects such as nausea, decreased appetite, or slight digestive discomfort
- An exclusive ingredient from Estnue, currently in the patent application process
Other Reported Vision Issues From Wegovy In addition to NAION, people with diabetes or cardiovascular risk factors who take Wegovy may still be at risk for other common eye conditions such as diabetic retinopathy, macular edema, or ocular migraines (although these conditions can occur in people not taking Wegovy)